SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-017427
Filing Date
2023-05-11
Accepted
2023-05-11 08:56:51
Documents
15
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bvs-20230511.htm   iXBRL 8-K 38855
2 EX-99.1 bvspressreleasefilingdelay.htm EX-99.1 10386
6 bioventuslogo.jpg GRAPHIC 15224
7 picture1.jpg GRAPHIC 8477
  Complete submission text file 0001628280-23-017427.txt   230336

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bvs-20230511.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bvs-20230511_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bvs-20230511_pre.xml EX-101.PRE 13582
9 EXTRACTED XBRL INSTANCE DOCUMENT bvs-20230511_htm.xml XML 11439
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

IRS No.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37844 | Film No.: 23909088
SIC: 3841 Surgical & Medical Instruments & Apparatus